![Andrew Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Smith
Finanzdirektor/CFO bei
Sucampo Pharma Europe Ltd.
Vermögen: 995 169 $ am 31.05.2026
Profil
Andrew P.
Smith was the founder of Clearlab Europe Ltd. (2001), holding the title of Finance Director (2004-2006).
Current jobs include Finance Director at Sucampo Pharma Europe Ltd. (2011-present), Director at Santhera Pharmaceuticals (USA), Inc. (present), Non-Executive Director at Arix Bioscience (2022-present), and Vice President-Operations & Finance at Sucampo GmbH (present).
Former jobs include Finance Director at 1-800 Contacts, Inc., Director at Tech Council of Maryland, Inc., Secretary & Finance Director at hVIVO Services Ltd. (2006-2009), Independent Non-Executive Director at Arix Bioscience Plc (2022-2024), Chief Financial Officer at Santhera Pharmaceuticals Holding AG (2020-2025), Chief Financial Officer at Sucampo Pharmaceuticals LLC (2011-2017), and Chief Financial & Operations Officer at Allecra Therapeutics GmbH (2017-2020).
Education includes a doctorate from the University of Durham and an undergraduate degree from Liverpool John Moores University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 47 704 ( 0,32 % ) | 995 169 $ | 31.05.2026 |
Aktive Positionen von Andrew Smith
| Unternehmen | Position | Beginn |
|---|---|---|
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapies for gastrointestinal, circulatory and ophthalmic diseases | Finanzdirektor/CFO | 10.03.2011 |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals and health care products | Finanzdirektor/CFO | 28.06.2012 |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Direktor/Vorstandsmitglied | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Direktor/Vorstandsmitglied | 01.08.2022 |
Ehemalige bekannte Positionen von Andrew Smith
| Unternehmen | Position | Ende |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Finanzdirektor/CFO | 24.02.2025 |
| ARIX BIOSCIENCE PLC | Direktor/Vorstandsmitglied | 01.02.2024 |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Finanzdirektor/CFO | 01.01.2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 20.03.2017 |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Finanzdirektor/CFO | 01.01.2009 |
Ausbildung von Andrew Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
1-800 Contacts, Inc.
 1-800 Contacts, Inc. Specialty StoresRetail Trade Sells contact lenses through online | Retail Trade |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Provides membership association services for technology and life science communities | Commercial Services |
Liverpool John Moores University
 Liverpool John Moores University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapies for gastrointestinal, circulatory and ophthalmic diseases | Commercial Services |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals and health care products | Health Technology |
Clearlab Europe Ltd. | |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Technology Services |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures pharmaceuticals to combat multi drug-resistant bacterial infections | Health Technology |
Arix Bioscience Plc
 Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Health Technology |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
Wählen Sie MarketScreener 
